ClinicalTrials.gg
RecruitingNCT03472404STRONGUpdated Jun 5, 2023

inStability Treated With Ligament RecOnstruction Augmented With iNternal bracinG

An interventional study of Internal Brace augmented ankle Ligament reconstruction and Brostrom-Gould ankle Ligament reconstruction in Ankle Sprains and Talofibular; Sprain (Strain), sponsored by Walter van der Weegen. Recruiting at 3 sites in Netherlands. Open to participants aged 16 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-06-05.

Sponsored by Walter van der Weegen · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Oct 2018; still recruiting 8 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
16 Years to 60 Years
Sex
All
01

Study summary

This study evaluates the effect of internal bracing in lateral ligament ankle surgery. Half of the patients will receive the standard Brostrom-Gould reconstruction followed by a standard revalidation protocol including 6 weeks of immobilisation, while the other half of the patients will receive the same operation augmented with internal brace followed by an accelerated rehabilitation protocol.

Read the detailed description

Ankle inversion trauma often leads to chronic ankle instability which can severely limit the patient during daily activities, including work and sports. When conservative treatment fails, surgical treatment in which the ruptured anterior talofibular ligament (ATFL) is reconstructed can be considered. Surgical treatment for ankle instability is associated with a relatively long rehabilitation due to the initial limited strength of the reconstructed ligament. This limited strength in the first weeks after surgery makes it necessary to protect the reconstructed lateral ankle ligament with immobilization. Usually a lower leg plaster is applied for six weeks. Due to the initial limited strength of the reconstructed ligament and the immobilization period itself, return to activities after surgery for this injury usually takes up to six months or even more. Therefore, surgical intervention is only indicated for patients who suffer chronic, recurrent ankle instability.

With a new surgical technique, an internal brace is placed over the reconstructed lateral ankle ligament, thereby providing protection which makes immobilization in the postoperative weeks unnecessary. This allows an earlier start of the rehabilitation which might enhance ankle function postoperatively and allows earlier return to activities. Also, adding an internal brace to the reconstructed lateral ankle ligament might result in a lower recurrence rate of ankle instability compared to the current surgical procedure.

Objective: To evaluate if patients with chronic, recurrent lateral ankle instability who are treated with surgical lateral ankle ligament repair protected with an internal brace, have significant better ankle function after surgery compared to patients treated with standard surgical lateral ankle ligament reconstruction without internal brace. The appropriately adapted rehabilitation for each surgery procedure is applied.

02

Conditions studied

  • Ankle Sprains
  • Talofibular; Sprain (Strain)
03

In context

Ankle Injuries

350 studies on the registry are indexed under Ankle Injuries; 74 are open to participants now.

This study's planned enrollment of 42 is below the median of 54 across 270 interventional studies indexed under Ankle Injuries.

Browse Ankle Injuries studies →

Lead sponsor

This is the only study on the registry with Walter van der Weegen as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients diagnosed with chronic lateral ankle instability (multiple ankle inversion trauma within 12 months and symptoms present >1 year). Lateral ankle instability is present if the patient complains of giving way of the ankle and has positive signs of ankle instability during physical exam (talar tilt score of >15 degrees compared to contralateral ankle or anterior drawer test score of >10mm compared to the contralateral ankle.
  • Conservative therapy has failed.
  • Normal foot and ankle anatomy as determined by orthopedic surgeon.
  • Patients in whom their ankle symptoms interfere with their physical activities.
  • Patients with isolated anterior talofibular ligament which is indicated for repair using the Brostrom-Gould technique.
  • ≤30
  • Patients who are able and willing to undergo ankle surgery.
  • Patients who are able and willing to comply with the rehabilitation protocol in any of the study physiotherapy centers.
  • Patients who are able and willing to return for follow-up evaluations.
  • Patients with sufficient understanding of the Dutch language.

Exclusion criteria

Exclusion Criteria:

  • Patients who need concomitant ankle surgery (i.e. Calcaneofibular ligament reconstruction, peroneus tendon repair, arthroscopy of the ankle, etc).
  • Patients with comorbidities, including musculoskeletal injuries or diseases in other joints than the affected ankle which limits their physical activity.
  • Ankle instability due to abnormal foot and ankle anatomy.
  • No objective or subjective ankle instability.
  • Previous ankle surgery.
  • Patients in which the contralateral ankle also shows lateral ankle instability.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Internal Brace augmented ankle Ligament reconstruction

    Procedure: Internal Brace augmented ankle Ligament reconstruction

  • Active comparator
    Control Group

    Brostrom-Gould ankle Ligament reconstruction

    Procedure: Brostrom-Gould ankle Ligament reconstruction

Interventions

  • ProcedureInternal Brace augmented ankle Ligament reconstruction

    internal brace augmented ankle ligament reconstruction and an accelerated revalidation protocol.

  • ProcedureBrostrom-Gould ankle Ligament reconstruction

    Brostrom-Gould and standard revalidation including 6 weeks immobilisation.

06

What researchers measure

Primary outcomes

  1. Change from baseline Foot Ankle Outcome Score (FAOS) at 12 months

    Patient reported outcome measure, consists of 42 items, each item is scored in a 5-point likert scale

    Time frame: pre-operative, post-operative at 12 months

07

Study locations

3 of 3 sites recruiting
  • Gelre Ziekenhuis
    Apeldoorn, Netherlands
    Recruiting
    • Pieter Bullens, MD · Contact
  • Medinova
    Breda, Netherlands
    Recruiting
    • Joost Schrier, MD, PhD · Contact
  • St Anna hospital
    Geldrop, 5664EH, Netherlands
    Recruiting
    • Walter van der weegen, PhD · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2018 (actual). Primary completion is estimated for Dec 2023, 62 months after the start.

Of 138 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 30. This study's planned 62 months is above that.

Counting every sponsor, half of 141 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2018
First posted
Mar 21, 2018
StartActual
Oct 1, 2018
Primary completionEst.
Dec 31, 2023
CompletionEst.
Dec 31, 2024
Last update
Jun 5, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03472404
Lead sponsor
Walter van der Weegen
Collaborators
Medinova Clinics, Gelre Hospitals
Responsible party
Walter van der Weegen (Principal Investigator, St. Anna Ziekenhuis, Geldrop, Netherlands) — Sponsor-investigator
First posted
Mar 21, 2018
Start date
Oct 1, 2018
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Jun 5, 2023

Study contacts

Walter van der Weegen, Dr.
Contact
w.vander.weegen@st-anna.nl
+31 (0) 40 2864 280
Walter van der Weegen, Dr.
principal investigator · St. Anna Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion